Cyclophosphamide treatment for hypertension and renal injury in an experimental model of systemic lupus erythematosus
Abstract Cardiovascular disease is the major cause of mortality among patients with the autoimmune disorder systemic lupus erythematosus (SLE). Our laboratory previously reported that immunosuppression with mycophenolate mofetil, a common therapy in patients with SLE, attenuates the development of h...
| 出版年: | Physiological Reports |
|---|---|
| 主要な著者: | , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Wiley
2019-05-01
|
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.14814/phy2.14059 |